Status:
RECRUITING
Prospective Study to Evaluate High Flow Nasal Cannula With Monitored Anesthesia Care During EBUS Bronchoscopy
Lead Sponsor:
The Cooper Health System
Conditions:
Lung Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Our objective is to assess whether the use of high flow nasal cannula (Vapotherm, Exeter, NH) with monitored anesthesia care (MAC) during an endobronchial ultrasound (EBUS) bronchoscopy procedure will...
Detailed Description
Background: MAC is a type of conscious sedation delivered by an anesthesiologist, during which different sedative medications are given, usually via the intravenous route, to obtain varying levels of...
Eligibility Criteria
Inclusion
- age\>18 years
- patient undergoing EBUS bronchoscopy with moderate conscious sedation.
Exclusion
- subjects with previous nasal surgeries
- subjects with oxygen saturation \<90% on room air prior to procedure
- subjects who are pregnant
- subjects with known facial fractures or recent facial trauma
- subjects on any anticoagulation that cannot be discontinued prior to the procedure
Key Trial Info
Start Date :
February 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2026
Estimated Enrollment :
198 Patients enrolled
Trial Details
Trial ID
NCT05203328
Start Date
February 1 2022
End Date
May 1 2026
Last Update
September 25 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cooper University Hospital
Camden, New Jersey, United States, 08103